fashion -WSS

fashion

author：Wikipedia 2025-10-03 00:07:39 - browse：35

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close.

What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtained by STAT. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons — a bitter legal fight in which his extramarital relationship with Langer is a contentious issue, according to the records.

Biogen spokesperson Jack Cox said the company knew about the relationship between Denner and Langer. He also said that Denner recommended Langer to Biogen’s board — he said he incorrectly stated at first that Denner nominated her — but declined to comment on the company’s vetting process and whether it planned to disclose the relationship to shareholders before they vote on Langer’s candidacy later this month. Biogen also omitted mention of the relationship from Langer’s biography in a Securities and Exchange Commission filing Tuesday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Using force crossed my mind when examining a defiant young patient

WSS

PEPFAR is under serious threat — and so is global health

Hospitals consider fixing cancer drug shortages on their own

Medicare isn't yet testing food as medicine

Doctor of U.S. President Joe Biden says he is fit for duty

NEJM study measures Covid brain fog, impact on IQ

Doctor of U.S. President Joe Biden says he is fit for duty

knowledge

fashion

knowledge

Affirmative action in medical school literally saved lives

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Walensky prepares to leave CDC — and Congress — behind

Private equity could exacerbate cardiology's overuse problem, experts fear

Affirmative action in medical school literally saved lives

Neuroscience renaissance leads to new crop of psychiatric drugs

Continuity nursing helped my family in our darkest PICU moments

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Psychedelics group wrestles with new pharma identity

Food makers to regulators: Ultra

leisure time

Virtual repurposing can help discover new uses for existing drugs

Neuroscience renaissance leads to new crop of psychiatric drugs

Long Covid needs a new name — and a new frame

Walmart eyes Medicare Advantage provider ChenMed

PEPFAR is under serious threat — and so is global health

Laying a path for careers in science

hotspot

leisure time

hotspot

explore